Jane Street’s Orphazyme A/S ORPH Stock Holding History

Jane Street’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-32,700	Closed	-$86K	–	11447
2021 Q4	$86K	Sell	32,700 -10,700	-25%	-$37.8K	﹤0.01%	9320
2021 Q3	$183K	Sell	43,400 -97,700	-69%	-$503K	﹤0.01%	8923
2021 Q2	$1.05M	Buy	+141,100	New	+$1.14M	﹤0.01%	5723

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Jane Street's ORPH Position: Q3 2021 in Review

Jane Street sold out of Orphazyme A/S (ORPH) in Q3 2021, closing a stake of 204,545 shares — an estimated $1.05M sold.

Jane Street first reported a position in ORPH in Q2 2021 and held it in 1 quarter. The position peaked at $1.53M in Q2 2021. 22 funds tracked by Wall St. Rank hold ORPH as of Q3 2021.

Jane Street reported no remaining Orphazyme A/S position as of Q3 2021 after selling out during the quarter.
Jane Street sold 204,545 Orphazyme A/S shares in Q3 2021, an estimated $1.05M.
Jane Street first reported a position in Orphazyme A/S in Q2 2021 and held it in 1 quarter.
Jane Street's Orphazyme A/S position peaked at $1.53M in Q2 2021.
22 funds tracked by Wall St. Rank held Orphazyme A/S as of Q3 2021.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.